![]() |
|
|
Vol. 28, Issue 4, 386-391, April 2000
Department of Pharmaceutics, School of Pharmacy, University
at Buffalo, State University of New York, Buffalo, New York
Volatile organic nitrites were originally used to relieve the chest
pain that is associated with angina pectoris. Today, these inhalants
are predominantly used as drugs of abuse. Little is known regarding the
bioavailability and disposition of volatile nitrites. In this study,
the pharmacokinetics of a major organic nitrite inhalant, isobutyl
nitrite (ISBN), and its primary metabolite, isobutyl alcohol (ISBA),
were investigated after inhalation and i.v. administration. ISBN blood
concentrations in the rat declined mono-exponentially with a half-life
of 1.4 min and a blood clearance of 2.9 l/min/kg that vastly exceeded
cardiac output (0.3 l/min/kg). Approximately 98% of ISBN was
metabolized to ISBA, which declined monoexponentially with a half-life
of 5.3 min when the infusion of ISBN was terminated. The
bioavailability of inhaled ISBN, over a range of 300 to 900 ppm, was
estimated to be 43%. After inhaled ISBN, the half-life of ISBA
decreased approximately 4-fold (t1/2 inh = 1.5 min versus t1/2 i.v. = 5.3 min; P < .001), whereas no pharmacokinetic
difference was observed for ISBN. Inhalation of another nitrite,
isoamyl nitrite, accelerated the apparent clearance of ISBA, suggesting
that nitrite inhalation could change the disposition of another
compound. A pharmacokinetic model was developed to describe the
concentration-time profile of ISBA and ISBN after inhalation and i.v. administration.